ABOUT
HISTORY
2000
- APR : Establish of legal company
- May : Venture company technology
registration approval
2011
-JAN : Product manufacturing license acquired
-Mar : CE approval (EGIS Esophageal Stent
/Guide Wire/Micro Catheter)
- May : Vietnamese plant begins operation
- Oct : Dealership contracts in Russia, Belgium,
Czech, Vietnam, Philippines, Saudi
2001
- Mar : Laboratory registered
- May : Begin of Stent study
- JUN : Capital increase
2012
- Feb : CE approval
- Aug : HQ moves to Seongnam
- Sep : KFDA approval
- Oct : Dealership contracts in Malaysia,
Spain, Estonia, Croatia, Indonesia
2002
- JUN : Chief executive officer change
- Dec : Moved company to Jayang-dong
2013
-JAN∼Dec : KFDA approval
-Feb : China SFDA product registration
ISO 13485 approval: Class III Seal
-APR : New product launches in Russia
-Aug : Additional CE approval
(Microcatehter & Guide Wire)
-Dec : Japanese PMDA product registration
- JAN-Dec : Worldwide product registration
2003
- JAN : Factory registration
- Aug : Venture company,
Laboratory approval
2014
- JAN∼Mar : Japanese QMS audit
and product launch
- Mar : CE extension review
- APR : China SFDA registration underway
2008
-JUL : CE approval (Extension)
EGIS Biliary/Pyloric/Colorectal stent)
-Sep : TAA overseas technology license
2017
-JUL : Completed S&G Head Office Building
in Yongin city
ABOUT
HISTORY
2000
- APR : Establish of legal company
- May : Venture company technology
registration approval
2001
- Mar : Laboratory registered
- May : Begin of Stent study
- JUN : Capital increase
2002
- JUN : Chief executive officer change
- Dec : Moved company to Jayang-dong
2003
- JAN : Factory registration
- Aug : Venture company,
Laboratory approval
2008
-JUL : CE approval (Extension)
EGIS Biliary/Pyloric/Colorectal stent)
-Sep : TAA overseas technology license
2011
-JAN : Product manufacturing license acquired
-Mar : CE approval (EGIS Esophageal Stent
/Guide Wire/Micro Catheter)
- May : Vietnamese plant begins operation
- Oct : Dealership contracts in Russia, Belgium,
Czech, Vietnam, Philippines, Saudi
2012
- Feb : CE approval
- Aug : HQ moves to Seongnam
- Sep : KFDA approval
- Oct : Dealership contracts in Malaysia,
Spain, Estonia, Croatia, Indonesia
2013
-JAN∼Dec : KFDA approval
-Feb : China SFDA product registration
ISO 13485 approval: Class III Seal
-APR : New product launches in Russia
-Aug : Additional CE approval
(Microcatehter & Guide Wire)
-Dec : Japanese PMDA product registration
- JAN-Dec : Worldwide product registration
2014
- JAN∼Mar : Japanese QMS audit
and product launch
- Mar : CE extension review
- APR : China SFDA registration underway
2017
-JUL : Completed S&G Head Office Building
in Yongin city
Gastrointestinal Radiology
- Doctor of Medicine : Chonbuk National University
- Master of Medicine : Chonbuk National University
- Bachelor of Medicine : Chonbuk National University
- Associate Professor in Chonbuk National University Hospital
- Assistant Professor in Chonbuk National University Hospital
- Clinical Instructor in Chonbuk National University Hospital
- Residency in Chonbuk National University Hospital
- Gastroduodenal stent placement versus surgical gastrojejunostomy for the palliation of gastric
outlet obstructions in patients with unresectable gastric cancer: a propensity score-matched analysis.
- Over-the-wire versus through-the-scope stents for the palliation of malignant gastric outlet
obstruction: A retrospective comparison study
(주) S&G바이오텍· 강성권
사업자등록번호 : 215-81-90549
통신판매업신고 : 제 2019-용인처인-0157호
E-mail : dkfma3876@sngbio.co.kr
예금주 : (주)에스앤지바이오텍
하나은행 346-910020-13104
070-5092-8824
월-금 am 09:00 - pm 06:00
주말, 공휴일 off
경기도 용인시 처인구 포곡읍 부곡로 82
(우)17023
ⓒ2021 (주) 에스앤지바이오텍